Info
Dr. Geoffrey Oxnard conveys a central theme that the benefits of molecular oncology and optimal application of targeted therapies are dependent on a change in collecting tissue that works to obtain far more tissue than was historically required.
8 anni fa
#alk, #cancer, #cancergrace, #collection, #core, #dana, #egfr, #geoffrey, #grace, #histology, #institute, #marker, #molecular, #mutation, #nsclc, #oncology, #oxnard, #rearrangement, #testing, #tissue
Scopri di più
Cerca
